Concord Medical Services: is shortlisted for the “5G + Healthcare” pilot project

BEIJING, October 18, 2021 / PRNewswire / – Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of ‘complete and medically autonomous hospitals. radiotherapy and diagnostic imaging centers in China, today announced that two of its projects, Jiahe Cloud Imaging Remote Medical Information Diagnosis Platform (“Cloud Jiahé“) and Jiahe Feiyun Intelligent Radiotherapy Cloud Service Platform (” Jiahe Feiyun “), were successfully shortlisted by the” 5G + Healthcare “pilot project, launched by the Ministry of Industry and Information Technology.

Cloud Jiahé provides digital solutions, with remote diagnostics as the main service, for medical institutions. The platform consists of six modules: remote diagnosis by regional imaging, bilateral referral, remote clinical consultation, distance training, cloud recording and reporting, and remote ECG / pathology / ultrasound diagnosis.

Jiahe Feiyun is one of six short-listed radiation therapy projects in the “5G + Healthcare” pilot project. It is a comprehensive service platform that provides a variety of services, including radiotherapy process management, target area demarcation, physician-to-physician clinical cooperation, remote quality control, multidisciplinary treatment. , distance learning, big data analysis, etc.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider specializing in cancer treatment, research, education and prevention. The Company operates a network of medically advanced comprehensive cancer hospitals and stand-alone radiotherapy and diagnostic imaging centers in China. The Company is focused on providing a multidisciplinary approach to cancer care in all areas of oncology services in its cancer hospitals. The Company also equips its hospitals with state-of-the-art equipment, such as the state-of-the-art proton therapy system in its high-end cancer hospitals located in major cities, including Beijing, Shanghai, and Canton. In addition, the Company saw the opportunity of the expanding medical equipment market by China and developed its product lifecycle management services from its existing medical equipment and consumables sales services. As of December 31, 2020, the Company operated a network of 27 radiotherapy centers and diagnostic imaging centers, based in 20 hospitals, established under long-term lease and management service agreements with the Company and covering more than 20 cities in 13 provinces and administrative regions of China. To ensure commitment to the highest standards of medical services for patients, the Company provides continuous education and training for physicians and other healthcare professionals in its hospitals and network centers in domestic and foreign medical institutions.

Safe Harbor Declaration

This announcement contains forward-looking statements. These forward-looking statements may be identified by words or expressions such as “will”, “expects”, “anticipates”, “the future”, “intention”, “plans”, “believes”, “ esteem ”and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the control of the Company and based on premises regarding future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company assumes no obligation to update any forward-looking statement, except as required by applicable law.


Show original content:

SOURCE Concord Medical Services Holdings Limited

Leave a Reply

Your email address will not be published.